Prolidase activity and oxidative stress in patients with major depressive disorder

Psychiatria Danubina

Volumn 26, Issue 4, 2014, Pages 314-318

  Kokacya, Mehmet Hanifi ^a   Bahceci, Bulent ^b   Bahceci, Ilkay ^b   Dilek, Aziz Ramazan ^b   Dokuyucu, Recep ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Major depressive disorder; MDD; Oxidative stress; Prolidase activity; Proline

Indexed keywords

GLUTAMIC ACID; PROLINE DIPEPTIDASE; DIPEPTIDASE;

ADULT; ARTICLE; COMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ETIOLOGY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROTRANSMISSION; OUTPATIENT DEPARTMENT; OXIDATIVE STRESS; PSYCHIATRIC DEPARTMENT; PSYCHIATRIST; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; BLOOD; PHYSIOLOGY;

ADULT; DEPRESSIVE DISORDER, MAJOR; DIPEPTIDASES; FEMALE; HUMANS; MALE; OXIDATIVE STRESS;

EID: 84909582699     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Akdemir A, Türkçapar MH, Örsel SD, Demirergi N, Dag I, Özbay MH: Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry 2001; 42:161-165.
2. Arikanoglu A, Akil E, Varol S, Yucel Y, Yuksel H, Cevik MU, et al: Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease. Neuro Sci 2013; 34:2117-2121.
3. Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Aksoy N, Celik H, Erel O: Serum prolidase activity and oxidative status in Helicobacter pylori. Clin Biochem 2007; 40:37-40.
4. Camuzoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N: Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2009; 147:97-100.
5. Chi H, Liu G, Tong J, Nakayama K, Yamashita K, Kitaoka N, Kodama H: Activity of prolidaseisoenzymes in the rat brain: subcellular and regional distribution during development. Brain Res 2009; 1303:8-14.
6. Cohen SM, Nadler JV: Proline-induced inhibition of glutamate release in hippocampal area CA1. Brain Res 1997b; 769:333-339.
7. Cohen SM, Nadler JV: Proline-induced potentiation of glutamate transmission. Brain Res 1997a; 761:271-282.
8. Crump FT, Fremeau RT, Craig AM: Localization of the brain-specific high-affinity I-proline transporter in cultured hippocampal neurons:molecular heterogeneity of synaptic terminals. Mol Cell Neurosci 1999; 13:25-39.
9. Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R: Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 2009; 63:639-45.
10. Delwing D, Bavaresco CS, Wannmacher CM, Wajner M, Dutra-Filho CS, Wyse AT: Proline induces oxidative stres in cerebral cortex of rats. Int J Dev Neurosci 2003; 21:105-110.
11. Delwing D, Sanna RJ, Wofchuk S, Weyse AT: Proline promotes decrease in glutamate uptake in slices of cerebral cortex and hippocampus of rats. Life Sci 2007; 81:1645-50.
12. Endo F, Matsuda I: Molecular basis of prolidase (peptidase D) deficiency. Mol Biol Med 1991; 8:117-27.
13. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38:1103-1111.
14. Erel O: A novel automated method to measure total antioxidant response aganist potent free radical reactions. Clin Biochem 2004;37:112-119.
15. Gibbon AS, Brooks L, Scarr E, Dean B: AMPA receptor expression is increased post-mortem samples of the anterior cingulated from subjects with major depressive disorder. J Affect Disord 2012; 136:1232-7.
16. Harma MI, Harma M, Erel O: Measuring plasma oxidative stress biomarkers in sport medicine. Eur J Appl Physiol 2006; 97:505.
17. Hauptmann M, Wilson DF, Erecinska M: High affinity proline uptake in rat brain synaptosomes. FEBS Lett 1983; 161:301-5.
18. Henzi V, Reichling DB, Helm SW, Mac Dermott AB: L-proline activates glutamate and glyncine receptors in cultured rat dorsal horn neurons. Mol Pharmacol 1992; 41:793-810.
19. Hui KS, Lajtha A: Prolidase activity in brain: comparison with other organs. J Neurochem 1978; 30:321-27.
20. Lupi A, Tenni R, Rossi A, Cetta G, Forlino A: Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids 2008; 35:739-52.
21. Maric NP, Adzic M: Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits. Psychiatr Danub 2013; 25:299-305.
22. Michel TM, Pulschen D, Thome J: The role of oxidative stress in depressive disorders. Curr Pharm Des 2012; 18:5890-9.
23. Mitsubuchi H, Nakamura K, Matsumoto S, Endo F: Inborn errors of proline metabolism. J Nutr 2008; 138:2016-2020.
24. Muller N: The role of anti-inflammatory treatment in psychiatric disorders. Psychiatr Danub 2013; 25:292-8.
25. Ortiz JG, Cordero ML, Rosado A: Proline-glutamate interactions in the CNS. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21:141-52.
26. Palucha A, Pilc A: The involvement of glutamate in the pathophysiology of depression. Drug News Perspect 2005; 18:262-8.
27. Rabus M, Demirbag R, Yildiz A, Tezcan O, Yilmaz R, Ocak AR, et al: Association of prolidase activity, oxidative parameters, and presence of atrial fibrillation inpatients with mitral stenosis. Arch Med Res 2008; 39:519-24.
28. Sayre LM, Smith MA, Perry G: Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Current medicinal chemistry 2001; 8:721-738.
29. Selek S, Altindag A, Saracoglu G, Celik H, Aksoy N: Prolidase activity and its diagnostic performance in bipolar disorder. J Affect Disord 2011; 129:84-86.
30. Wu G, Bazer FW, Burghardt RC, Johnson GA, Knabe DA, Li P, et al: Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids 2011; 40:1053-1063.
31. Wyse AT, Netto C: Behavioral and neurochemical effects of proline. Metab Brain Dis 2011; 26:159-72.
32. Yanik M, Erel O, Kati M: The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 2004; 16:200-3.
33. Yu XC, Zhang W, Oldham A, Buxton E, Patel S, Nghi N, et al: Discoverry and characterization of potent small molecule inhibitors of the high affinity proline transporter. Neurosci Lett 2009; 451:212-216.
34. Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G: Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994; 79:13-8.